Company witnessed QoQ revenue decline of 31.33%, which is lowest in the last 3 years. (Source: Standalone Financials)
Smruthi Organics Share Price
Smruthi Organics Share ...
Smruthi Org share price insights
Stock gave a 3 year return of -57.17% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)
Sales de-grew by 9.51%. Company witnessed revenue contraction for the first time in last 3 years. (Source: Standalone Financials)
Stock generated -57.17% return as compared to Nifty Pharma which gave investors 64.02% return over 3 year time period. (as of last trading session)
Smruthi Organics Ltd. share price moved down by -4.68% from its previous close of Rs 149.45. Smruthi Organics Ltd. stock last traded price is 142.45
Share Price Value Today/Current/Last 142.45 Previous Day 149.45
Key Metrics
PE Ratio (x) | 436.32 | ||||||||||
EPS - TTM (₹) | 0.33 | ||||||||||
MCap (₹ Cr.) | 163.05 | ||||||||||
Sectoral MCap Rank | 121 | ||||||||||
PB Ratio (x) | 2.46 | ||||||||||
Div Yield (%) | 1.05 | ||||||||||
Face Value (₹) | 10.00 | ||||||||||
Beta Beta
| -0.15 | ||||||||||
VWAP (₹) | 144.68 | ||||||||||
52W H/L (₹) |
Smruthi Org Share Price Returns
1 Day | -4.68% |
1 Week | -2.13% |
1 Month | -10.44% |
3 Months | -14.68% |
1 Year | -11.8% |
3 Years | -57.17% |
5 Years | N.A. |
Smruthi Org News & Analysis
Smruthi Org Share Recommendations
Recent Recos
Current
Mean Recos by 1 Analysts
SellSellHoldBuyStrong
Buy
That's all for Smruthi Org recommendations. Check out other stock recos.
Analyst Trends
Ratings | Current | 1 Week Ago | 1 Month Ago | 3 Months Ago |
---|---|---|---|---|
Strong Buy | - | - | - | 1 |
Buy | 1 | 1 | 1 | - |
Hold | - | - | - | - |
Sell | - | - | - | - |
Strong Sell | - | - | - | - |
# Analysts | 1 | 1 | 1 | 1 |
Smruthi Org Financials
Income (P&L)
Balance Sheet
Cash Flow
Ratios
Insights
Quarterly Topline Performance
Company witnessed QoQ revenue decline of 31.33%, which is lowest in the last 3 years. (Source: Standalone Financials)Topline Contraction
Sales de-grew by 9.51%. Company witnessed revenue contraction for the first time in last 3 years. (Source: Standalone Financials)
Quarterly | Annual Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023 Total Income 27.27 39.72 23.48 29.59 34.92 Total Income Growth (%) -31.33 69.14 -20.65 -15.26 -5.18 Total Expenses 28.12 37.16 26.11 26.54 31.53 Total Expenses Growth (%) -24.33 42.31 -1.60 -15.85 -11.85 EBIT -0.85 2.56 -2.63 3.06 3.39 EBIT Growth (%) -133.09 - -185.96 -9.81 220.43 Profit after Tax (PAT) -0.92 1.52 -2.29 2.07 2.29 PAT Growth (%) -160.75 - -210.76 -9.76 232.14 EBIT Margin (%) -3.10 6.44 -11.19 10.33 9.71 Net Profit Margin (%) -3.38 3.83 -9.76 6.99 6.57 Basic EPS (₹) -0.81 1.33 -2.00 1.81 2.00 All figures in Rs Cr, unless mentioned otherwise
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Total Assets 118.19 105.64 87.61 91.82 87.75 Total Assets Growth (%) 11.88 20.58 -4.59 4.64 -13.04 Total Liabilities 48.57 37.48 20.45 31.33 45.29 Total Liabilities Growth (%) 29.59 83.28 -34.73 -30.82 -29.82 Total Equity 69.62 68.16 67.16 60.49 42.46 Total Equity Growth (%) 2.14 1.49 11.03 42.46 16.71 Current Ratio (x) 1.79 1.84 3.42 2.38 1.40 Total Debt to Equity (x) 0.17 0.08 0.04 0.16 0.37 Contingent Liabilities 1.30 1.49 0.95 0.39 0.27 All figures in Rs Cr, unless mentioned otherwise
Insights
Decrease in Cash from Investing
Company has used Rs 7.16 cr for investing activities which is an YoY decrease of 30.08%. (Source: Standalone Financials)
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Net Cash flow from Operating Activities 4.40 12.11 1.91 22.82 21.43 Net Cash used in Investing Activities -7.16 -10.25 -5.87 -3.40 -4.52 Net Cash flow from Financing Activities 2.66 -1.52 -11.62 -6.86 -17.49 Net Cash Flow -0.11 0.34 -15.58 12.57 -0.58 Closing Cash & Cash Equivalent 0.48 0.59 0.57 16.14 3.57 Closing Cash & Cash Equivalent Growth (%) -18.22 3.58 -96.49 351.83 -14.04 Total Debt/ CFO (x) 2.66 0.47 1.51 0.43 0.73 All figures in Rs Cr, unless mentioned otherwise
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Return on Equity (%) 5.15 6.06 15.45 28.28 19.89 Return on Capital Employed (%) 8.37 7.57 20.41 37.51 30.63 Return on Assets (%) 3.03 3.91 11.84 18.63 9.62 Interest Coverage Ratio (x) 8.54 12.02 19.33 23.00 4.80 Asset Turnover Ratio (x) 1.14 1.46 1.49 137.76 149.37 Price to Earnings (x) 46.73 35.71 24.69 14.88 3.25 Price to Book (x) 2.40 2.16 3.82 4.21 0.65 EV/EBITDA (x) 14.82 15.27 13.60 8.53 2.01 EBITDA Margin (%) 9.42 7.01 14.25 22.99 14.99
Smruthi Org Peer Comparison
Smruthi Org Stock Performance
Ratio Performance
Insights
Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of -55.07% as compared to Nifty Smallcap 100 which gave a return of 92.43%. (as of last trading session)Stock Returns vs Nifty Pharma
Stock generated -55.07% return as compared to Nifty Pharma which gave investors 64.81% return over 3 year time period. (as of last trading session)
Choose from Peers
Choose from Stocks
- 1D
- 1W
- 1M
- 3M
- 6M
- 1Y
- 5Y
Loading...Insights
Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of -57.17% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)Stock Returns vs Nifty Pharma
Stock generated -57.17% return as compared to Nifty Pharma which gave investors 64.02% return over 3 year time period. (as of last trading session)
See All Parameters
MF Ownership
MF Ownership details are not available.
Corporate Actions
Smruthi Org Board Meeting/AGM
Smruthi Org Dividends
- Others
Meeting Date Announced on Purpose Details Jul 27, 2024 Jul 18, 2024 Board Meeting Quarterly Results May 06, 2024 Apr 26, 2024 Board Meeting Audited Results & Final Dividend Feb 03, 2024 Jan 24, 2024 Board Meeting Quarterly Results Nov 09, 2023 Oct 31, 2023 Board Meeting Quarterly Results Aug 05, 2023 Jul 26, 2023 Board Meeting Quarterly Results Type Dividend Dividend per Share Ex-Dividend Date Announced on Final 15% 1.5 Sep 06, 2024 May 06, 2024 Final 20% 2.0 Jul 28, 2023 May 22, 2023 Final 30% 3.0 Jul 28, 2022 May 30, 2022 Final 30% 3.0 Jul 01, 2021 Apr 23, 2021 Interim 30% 3.0 Mar 19, 2020 Mar 11, 2020 All Types Ex-Date Record Date Announced on Details Bonus Mar 16, 2021 Mar 17, 2021 Jan 16, 2021 Bonus Ratio: 2 share(s) for every 1 shares held
About Smruthi Org
Smruthi Organics Ltd., incorporated in the year 1989, is a Small Cap company (having a market cap of Rs 163.05 Crore) operating in Pharmaceuticals sector. Smruthi Organics Ltd. key Products/Revenue Segments include Bulk Drugs (Intermediates), Export Incentives for the year ending 31-Mar-2024. Show More
Executives
Auditors
- PE
Purushotham Eaga
Chairman & Managing DirectorSESwapnil Eaga
Joint Managing Director & CFOSESmruthi Eaga
Non Exe.Non Ind.DirectorADAnoop Doshi
Ind. Non-Executive DirectorShow More - Gokhale & SatheN R Waghchaure & Associates
Industry
Key Indices Listed on
-
Address
165-A, Balaji Bhavan,1st Floor,Solapur, Maharashtra - 413001
More Details
FAQs about Smruthi Org share
- 1. What's Smruthi Org share price today and what are Smruthi Org share returns ?Smruthi Org share price was Rs 142.45 as on 29 Aug, 2024, 03:49 PM IST. Smruthi Org share price was down by 4.68% based on previous share price of Rs. 152.25.
- 2. What are the Smruthi Org quarterly results?On Standalone basis, Smruthi Org reported a total income and loss of Rs 27.27 Cr and Rs -0.92 respectively for quarter ending resultQuarterlyResult.list[0].yearEnding. Total Income and profit for the year ending 2024-03-31 was Rs 127.72 Cr and Rs 3.59 Cr.
- 3. Who's the chairman of Smruthi Org?Purushotham Eaga is the Chairman & Managing Director of Smruthi Org
- 4. Who are the peers for Smruthi Org in Pharmaceuticals sector?Within Pharmaceuticals sector Smruthi Org, Krebs Biochemicals & Industries Ltd., Aarey Drugs & Pharmaceuticals Ltd., Tyche Industries Ltd., BDH Industries Ltd., Bal Pharma Ltd., Mangalam Drugs and Organics Ltd., Pharmaids Pharmaceuticals Ltd., Alpa Laboratories Ltd., Lactose (India) Ltd. and Bafna Pharmaceuticals Ltd. are usually compared together by investors for analysis.
- 5. What is the recommendation for Smruthi Org - Buy or Sell?As per Refinitiv (erstwhile Thomson Reuters), overall mean recommendation by 1 analyst for Smruthi Org stock is to Buy. Recommendation breakup is as follows
- 1 analyst is recommending to Buy
- 6. What is the CAGR of Smruthi Org?The CAGR of Smruthi Org is 0.22.
- 7. What is the PE & PB ratio of Smruthi Org?The PE ratio of Smruthi Org stands at 457.76, while the PB ratio is 2.46.
- 8. What has been highest price of Smruthi Org share in last 52 weeks?52 Week high of Smruthi Org share is Rs 218.80 while 52 week low is Rs 139.00
- 9. What dividend is Smruthi Org giving?Smruthi Organics Ltd. announced an equity dividend of 15% on a face value of 10.0 amounting to Rs 1.5 per share on 06 May 2024. The ex dividend date is 06 Sep 2024.
- 10. What's the market capitalization of Smruthi Org?Market Capitalization of Smruthi Org stock is Rs 163.05 Cr.
- 11. What are the returns for Smruthi Org share?Return Performance of Smruthi Org Shares:
- 1 Week: Smruthi Org share price moved down by 2.13%
- 3 Month: Smruthi Org share price moved down by 14.68%
- 6 Month: Smruthi Org share price moved down by 11.27%
- 12. How can I quickly analyze Smruthi Org stock?Key Metrics for Smruthi Org are:
- PE Ratio of Smruthi Org is 436.32
- Price/Sales ratio of Smruthi Org is 1.31
- Price to Book ratio of Smruthi Org is 2.46
- 13. Who are the key owners of Smruthi Org stock?
- Promoter holding has gone up from 63.58 (30 Sep 2023) to 63.87 (30 Jun 2024)
- Other investor holding have gone down from 36.42 (30 Sep 2023) to 36.13 (30 Jun 2024)
Trending in Markets
Smruthi Org Quick Links
Equity Quick Links
More from Markets
IPOStock market news
Budget 2022 Live Updates
Cryptocurrency
Currency converter
NSE holiday list
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.